ジェネリック医薬品のアジア太平洋市場

◆英語タイトル:Generics in Asia-Pacific
◆商品コード:MLN20DC243
◆発行会社(リサーチ会社):MarketLine
◆発行日:2020年8月18日
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア太平洋
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD1,050 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Generics in Asia-Pacific
Summary

Generics in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the ‘generic-eligible’ market, are not included.
- The Asia-Pacific generics market had total revenues of $129.9bn in 2019, representing a compound annual growth rate (CAGR) of 7.3% between 2015 and 2019.
- Market consumption volume increased with a CAGR of 2.6% between 2015 and 2019, to reach a total of 76.8% in 2019.
- China accounted for 53.7% of the value of the Asia-Pacific market in the 2019, followed by Japan and India with 21.1% and 12.7%, respectively.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Asia-Pacific
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Asia-Pacific
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific generics market with five year forecasts by both value and volume

Reasons to Buy

- What was the size of the Asia-Pacific generics market by value in 2019?
- What will be the size of the Asia-Pacific generics market in 2024?
- What factors are affecting the strength of competition in the Asia-Pacific generics market?
- How has the market performed over the last five years?
- How large is Asia-Pacific’s generics market in relation to its regional counterparts?

【レポートの目次】

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the outbreak of COVID-19 impacted leading players?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Mylan N.V.
8.3. Sun Pharmaceutical Industries Ltd
8.4. Pfizer Inc.
9 Appendix
9.1. Methodology
9.2. About MarketLine

List of Tables
Table 1: Asia-Pacific generics market value: $ billion, 2015-19
Table 2: Asia-Pacific generics market volume: % of total pharma, 2015-19
Table 3: Asia-Pacific generics market geography segmentation: $ billion, 2019
Table 4: Asia-Pacific generics market value forecast: $ billion, 2019-24
Table 5: Asia-Pacific generics market volume forecast: % of total pharma, 2019-24
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Mylan N.V.: key facts
Table 10: Mylan N.V.: Annual Financial Ratios
Table 11: Mylan N.V.: Key Employees
Table 12: Sun Pharmaceutical Industries Ltd: key facts
Table 13: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 14: Sun Pharmaceutical Industries Ltd: Key Employees
Table 15: Pfizer Inc.: key facts
Table 16: Pfizer Inc.: Annual Financial Ratios
Table 17: Pfizer Inc.: Key Employees
Table 18: Pfizer Inc.: Key Employees Continued

List of Figures
Figure 1: Asia-Pacific generics market value: $ billion, 2015-19
Figure 2: Asia-Pacific generics market volume: % of total pharma, 2015-19
Figure 3: Asia-Pacific generics market geography segmentation: % share, by value, 2019
Figure 4: Asia-Pacific generics market value forecast: $ billion, 2019-24
Figure 5: Asia-Pacific generics market volume forecast: % of total pharma, 2019-24
Figure 6: Forces driving competition in the generics market in Asia-Pacific, 2019
Figure 7: Drivers of buyer power in the generics market in Asia-Pacific, 2019
Figure 8: Drivers of supplier power in the generics market in Asia-Pacific, 2019
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2019
Figure 10: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2019
Figure 11: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2019

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ジェネリック医薬品のアジア太平洋市場]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆